JULIAN BAKER Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JULIAN BAKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JULIAN BAKER. JULIAN BAKER is Director in INCYTE CORP ($INCY) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in XOMA Corp ($XOMA) and 10% Owner in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in GENOMIC HEALTH INC ($GHDX).
JULIAN BAKER in SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JULIAN BAKER: Director, 10% Owner
Holdings: 9,184,771 shares
Latest Transaction: Jan 09 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JULIAN BAKER in SYNAGEVA BIOPHARMA CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GHDX, IDRA, INCY, GEVA, XOMA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 94.19 | 1,000,000 | 94,190,000 | 9,184,771 | 8.2 M to 9.2 M (+12.22 %) |
| Mar 07 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 105.75 | 9,031 | 955,028 | 211,614 | 202.6 K to 211.6 K (+4.46 %) |
| Mar 07 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 105.75 | 365,969 | 38,701,222 | 8,172,521 | 7.8 M to 8.2 M (+4.69 %) |
| Sep 27 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 56.63 | 25,663 | 1,453,296 | 202,583 | 176.9 K to 202.6 K (+14.51 %) |
| Sep 27 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 56.63 | 1,024,337 | 58,008,204 | 7,806,552 | 6.8 M to 7.8 M (+15.10 %) |
| Jan 08 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 47.53 | 20,099 | 955,305 | 176,920 | 156.8 K to 176.9 K (+12.82 %) |
| Jan 08 2013 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 47.53 | 839,621 | 39,907,186 | 6,782,215 | 5.9 M to 6.8 M (+14.13 %) |
| Jul 13 2012 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 41.20 | 21,082 | 868,578 | 156,821 | 135.7 K to 156.8 K (+15.53 %) |
| Jul 13 2012 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | P | 41.20 | 864,918 | 35,634,622 | 5,942,594 | 5.1 M to 5.9 M (+17.03 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | 10% Owner | Grant | A | 0.00 | 135,462 | 0 | 144,082 | 8.6 K to 144.1 K (+1,571.48 %) |
Page: 1